Department of Urology, Ondokuz Mayis University, Samsun, Turkey.
Department of Urology, Gazi State Hospital, Samsun, Turkey.
Int J Clin Pract. 2021 Oct;75(10):e14611. doi: 10.1111/ijcp.14611. Epub 2021 Jul 20.
To our knowledge, this is the first study investigating the impact of high visceral adiposity index (VAI) on female sexual dysfunction (FSD). We aimed to show the impact of increased levels of VAI on FSD compared with body mass index (BMI) and waist circumference (WC) particularly in those with metabolic syndrome (MeTS).
We included 158 participants in two groups: Group 1 (n = 68 with normal sexual function) and Group 2 (n = 90 with sexual dysfunction). Demographic, clinic data, presence of MeTS and comorbidities were recorded. The BMI, WC and the VAI were calculated. Sexual function was assessed using the female sexual function index.
The mean age and all the anthropometric variables were similar between the groups (P > .05). MeTS was associated with lower arousal and lubrication scores than those without MeTS (P = .023). The higher VAI was associated with lower desire, lubrication and orgasm scores (P < .05). Each integer increase of the VAI weakly predicted decrease of desire (P = .015), arousal (P = .015), lubrication (P = .005) and satisfaction (P = .046). The WC and BMI were not a good predictor for FSD in women (OR=1.019, P = .318).
The VAI was linked with lower scores in some female sexual function subdomains, but the correlation coefficient was low, indicating a weak association. Further studies with a higher number of participants are needed to conclude that the VAI may increase the risk of FSD, particularly in patients with MeTS.
据我们所知,这是第一项研究,旨在探讨高内脏脂肪指数(VAI)对女性性功能障碍(FSD)的影响。我们旨在展示与体重指数(BMI)和腰围(WC)相比,VAI 水平升高对 FSD 的影响,特别是在代谢综合征(MeTS)患者中。
我们将 158 名参与者分为两组:第 1 组(n=68 名性功能正常)和第 2 组(n=90 名性功能障碍)。记录人口统计学、临床数据、MeTS 存在情况和合并症。计算 BMI、WC 和 VAI。使用女性性功能指数评估性功能。
两组的平均年龄和所有人体测量学变量均相似(P>.05)。MeTS 与较低的唤醒和润滑评分相关,而与无 MeTS 者相比(P=.023)。较高的 VAI 与较低的欲望、润滑和性高潮评分相关(P<.05)。VAI 每增加一个整数,欲望(P=.015)、唤醒(P=.015)、润滑(P=.005)和满意度(P=.046)均呈下降趋势。WC 和 BMI 不是女性 FSD 的良好预测指标(OR=1.019,P=.318)。
VAI 与一些女性性功能领域的评分较低相关,但相关系数较低,表明相关性较弱。需要更多参与者的进一步研究来得出结论,即 VAI 可能会增加 FSD 的风险,特别是在 MeTS 患者中。